Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Groen

Showing results (381-390 of 564) with videos related to

Pageof 57
Sort By:
Intensive Care Medicine|October 22, 2003
Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patientsClaudi S M Oude Nijhuis, Edo Vellenga, Simon M G J Daenen, et al.
European Journal of Cancer (Oxford, England : 1990)|October 10, 2017
A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in patients with advanced non-small cell lung cancerJean-Charles Soria, Alex A Adjei, Rastilav Bahleda, et al.
Lung Cancer (Amsterdam, Netherlands)|June 15, 2020
Combined osimertinib, dabrafenib and trametinib treatment for advanced non-small-cell lung cancer patients with an osimertinib-induced BRAF V600E mutationPei Meng, Bart Koopman, Klaas Kok, et al.
British Journal of Cancer|October 2, 2003
First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trialF M Wachters, J W G Van Putten, H Kramer, et al.
Critical Reviews in Oncology/Hematology|November 5, 2002
Fever and neutropenia in cancer patients: the diagnostic role of cytokines in risk assessment strategiesC S M Oude Nijhuis, S M G J Daenen, E Vellenga, et al.
Clinical Lung Cancer|April 11, 2020
A Subsolid Nodules Imaging Reporting System (SSN-IRS) for Classifying 3 Subtypes of Pulmonary AdenocarcinomaXiaonan Cui, Marjolein A Heuvelmans, Shuxuan Fan, et al.
European Journal of Hybrid Imaging|May 22, 2018
Somatostatin receptor based hybrid imaging in sarcoidosisRiemer H J A Slart, Klaas-Pieter Koopmans, Peter Paul van Geel, et al.
British Journal of Anaesthesia|November 5, 2013
Bispectral index values and propofol concentrations at loss and return of consciousness in patients with frontal brain tumours and control patientsM M Sahinovic, U Beese, E H Heeremans, et al.
Acta Oncologica (Stockholm, Sweden)|July 2, 2019
Factors determining the effect of prophylactic cranial irradiation (PCI) in patients with stage-III nonsmall cell lung cancer: exploratory subgroup analyses of the NVALT-11/DLCRG-02 phase-III studyW J A Witlox, B L T Ramaekers, H J M Groen, et al.
Journal of Neurology|January 9, 2022
Transient neurological deficit in patients with chronic subdural hematoma: a retrospective cohort analysisJurre Blaauw, Heleen M den Hertog, Josje M van Zundert, et al.
Pageof 57

Showing results (381-390 of 564) with videos related to

Sort By:
Pageof 57
Intensive Care Medicine|October 22, 2003
Lipopolysaccharide-binding protein: a possible diagnostic marker for Gram-negative bacteremia in neutropenic cancer patientsClaudi S M Oude Nijhuis, Edo Vellenga, Simon M G J Daenen, et al.
European Journal of Cancer (Oxford, England : 1990)|October 10, 2017
A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin (with or without bevacizumab) or pemetrexed and cisplatin (with or without bevacizumab) in patients with advanced non-small cell lung cancerJean-Charles Soria, Alex A Adjei, Rastilav Bahleda, et al.
Lung Cancer (Amsterdam, Netherlands)|June 15, 2020
Combined osimertinib, dabrafenib and trametinib treatment for advanced non-small-cell lung cancer patients with an osimertinib-induced BRAF V600E mutationPei Meng, Bart Koopman, Klaas Kok, et al.
British Journal of Cancer|October 2, 2003
First-line gemcitabine with cisplatin or epirubicin in advanced non-small-cell lung cancer: a phase III trialF M Wachters, J W G Van Putten, H Kramer, et al.
Critical Reviews in Oncology/Hematology|November 5, 2002
Fever and neutropenia in cancer patients: the diagnostic role of cytokines in risk assessment strategiesC S M Oude Nijhuis, S M G J Daenen, E Vellenga, et al.
Clinical Lung Cancer|April 11, 2020
A Subsolid Nodules Imaging Reporting System (SSN-IRS) for Classifying 3 Subtypes of Pulmonary AdenocarcinomaXiaonan Cui, Marjolein A Heuvelmans, Shuxuan Fan, et al.
European Journal of Hybrid Imaging|May 22, 2018
Somatostatin receptor based hybrid imaging in sarcoidosisRiemer H J A Slart, Klaas-Pieter Koopmans, Peter Paul van Geel, et al.
British Journal of Anaesthesia|November 5, 2013
Bispectral index values and propofol concentrations at loss and return of consciousness in patients with frontal brain tumours and control patientsM M Sahinovic, U Beese, E H Heeremans, et al.
Acta Oncologica (Stockholm, Sweden)|July 2, 2019
Factors determining the effect of prophylactic cranial irradiation (PCI) in patients with stage-III nonsmall cell lung cancer: exploratory subgroup analyses of the NVALT-11/DLCRG-02 phase-III studyW J A Witlox, B L T Ramaekers, H J M Groen, et al.
Journal of Neurology|January 9, 2022
Transient neurological deficit in patients with chronic subdural hematoma: a retrospective cohort analysisJurre Blaauw, Heleen M den Hertog, Josje M van Zundert, et al.
Pageof 57